3-[(4-Phenylmethoxypyrimidin-2-yl)amino]benzamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-[(4-Phenylmethoxypyrimidin-2-yl)amino]benzamide
• 化学式: C₁₈H₁₆N₄O₂
• 分子量: 320.3
• InChiKey: IDUKDIZBYUBKLN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  90.1
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
  申请人：Freyne Edgard Eddy Jean

  公开号：US20060063789A1

  公开（公告）日：2006-03-23

  This invention concerns a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein ring A represents a 6-membered heterocycle; R 1 is hydrogen; aryl; formyl; C 1-6 alkylcarbonyl; optionally substituted C 1-6 alkyl; C 1-6 alkyloxycarbonyl; optionally substituted C 1-6 alkyloxyC 1-6 alkylcarbonyl; X is a direct bond or a linker atom or group; Z is O or S; R 2 is hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, a carbocycle or a heterocycle, each of said groups may optionally be substituted; R 3 is hydrogen; hydroxy; halo; optionally substituted C 1-6 alkyl or C 2-6 alkenyl or C 2-6 alkynyl; C 1-6 alkyloxy; C 1-6 alkylthio; C 1-6 alkyloxycarbonyl; C 1-6 alkylcarbonyloxy; carboxyl; cyano; nitro; amino; mono- or di(C 1-6 alkyl)amino; polyhaloC 1-6 alkyl; polyhaloC 1-6 alkyloxy; polyhaloC 1-6 alkylthio; R 21 ; R 21 —C 1-6 alkyl; R 21 —O—; R 21 —S—; R 21 —C(═O)—; R 21 —S(═O) p —; R 7 —S(═O) p —; R 7 —S(═O) p —NH—; R 21 —S(═O) p —NH—; R 7 —C(═O)—; —NHC(═O)H; —C(═O)NHNH 2 ; R 7 —C(═O)—NH—; R 21 —C(═O)—NH—; —C(═NH)R 7 ; —C(═NH)R 21 ; R 4a or R 4b each independently represent hydrogen, R 8 , —Y 1 —NR 9 —Y 2 —NR 10 R 11 , —Y 1 —NR 9 —Y 1 —R 8 , —Y 1 —NR 9 R 10 ; provided that —X—R 2 and/or R 3 is other than hydrogen; their use, pharmaceutical compositions comprising them and processes for their preparation.

  本发明涉及公式a的化合物，其为N-氧化物、药学上可接受的加合盐、季铵盐及其立体化学异构体，其中环A代表一个6元杂环；R1为氢；芳基；甲酰基；C1-6烷基羰基；可选择取代的C1-6烷基；C1-6烷氧羰基；可选择取代的C1-6烷氧基C1-6烷基羰基；X为直接键或连接原子或基团；Z为氧或硫；R2为氢、C1-10烷基、C2-10烯基、C2-10炔基、碳环或杂环，其中每个所述基团均可选择性地被取代；R3为氢；羟基；卤素；可选择取代的C1-6烷基或C2-6烯基或C2-6炔基；C1-6烷氧基；C1-6烷硫基；C1-6烷氧羰基；C1-6烷基羰酸酯基；羧基；氰基；硝基；氨基；单烷基或双(C1-6烷基)氨基；多卤C1-6烷基；多卤C1-6烷氧基；多卤C1-6烷硫基；R21；R21—C1-6烷基；R21—O—；R21—S—；R21—C(═O)—；R21—S(═O)p—；R7—S(═O)p—；R7—S(═O)p—NH—；R21—S(═O)p—NH—；R7—C(═O)—；—NHC(═O)H；—C(═O)NHNH2；R7—C(═O)—NH—；R21—C(═O)—NH—；—C(═NH)R7；—C(═NH)R21；R4a或R4b各自独立地代表氢、R8、—Y1—NR9—Y2—NR10R11、—Y1—NR9—Y1—R8、—Y1—NR9R10；前提是—X—R2和/或R3不为氢；其用途、包含它们的制药组合物以及它们的制备方法。
• AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS
  申请人：Janssen Pharmaceutica NV

  公开号：EP1442024B1

  公开（公告）日：2008-03-19